Bjorkquist Jeanette M 4
4 · ASSEMBLY BIOSCIENCES, INC. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Assembly Biosciences (ASMB) PFO Jeanette Bjorkquist Receives Award
What Happened
Jeanette M. Bjorkquist, the company's PFO & PAO (Principal Financial Officer and Principal Accounting Officer), was granted 3,500 restricted stock units (RSUs) on March 29, 2026. The RSUs were reported at $0.00 per share (award), so no cash was exchanged (total reported value $0). The grant represented 35% of her annual equity award approved March 29, 2026 and was contingent on a stockholder-approved amendment to the company’s 2018 Stock Incentive Plan.
Key Details
- Transaction type/date: Award (code A) granted March 29, 2026; Form 4 filed June 5, 2026.
- Price: $0.00 per share; 3,500 RSUs granted (total reported value $0).
- Issuance condition: RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026.
- Vesting: Four approximately equal installments, assuming continuous service, on March 29 of 2027, 2028, 2029 and 2030.
- Shares owned after transaction: Not stated in the provided filing excerpt.
- Filing timeliness: The Form 4 was filed more than two months after the grant date (filed June 5 for a March 29 transaction), indicating a late report under standard Section 16 timing—this delays public visibility of the award.
Context
RSU grants are a form of compensation and do not reflect an open-market purchase or sale. These units become actual shares only if and when they are issued and vest; they generally require continued employment to vest and are not immediately liquid. Because this grant was contingent on a plan amendment and vests over four years, it primarily reflects compensation structure rather than a near-term insider market signal.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-29+3,500→ 14,589 total
Footnotes (1)
- [F1]Restricted stock units ("RSUs") representing 35% of the reporting person's annual equity grant, which was approved on March 29, 2026 and was contingent upon stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Stock Incentive Plan (the "Plan") that increased the number of shares of common stock authorized for issuance under the Plan (the "Plan Amendment"). Although the RSUs were granted on March 29, 2026, the RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026 and vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2027; March 29, 2028; March 29, 2029; and March 29, 2030.